Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.

@article{Gnthard2016AntiretroviralDF,
  title={Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.},
  author={Huldrych F. G{\"u}nthard and Michael S Saag and Constance Ann Benson and Carlos Del Rio and Joseph J Eron and Joel E. Gallant and Jennifer F Hoy and Michael J Mugavero and Paul E Sax and Melanie Anne Thompson and Rajesh T Gandhi and Raphael J Landovitz and Davey M. Smith and Donna M. Jacobsen and Paul A. Volberding},
  journal={JAMA},
  year={2016},
  volume={316 2},
  pages={
          191-210
        }
}
IMPORTANCE New data and therapeutic options warrant updated recommendations for the use of antiretroviral drugs (ARVs) to treat or to prevent HIV infection in adults. OBJECTIVE To provide updated recommendations for the use of antiretroviral therapy in adults (aged ≥18 years) with established HIV infection, including when to start treatment, initial regimens, and changing regimens, along with recommendations for using ARVs for preventing HIV among those at risk, including preexposure and… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 182 CITATIONS, ESTIMATED 51% COVERAGE

Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2018
VIEW 9 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy?

  • Annals of Clinical Microbiology and Antimicrobials
  • 2017
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

HIV in the dialysis population: Current issues and future directions.

VIEW 11 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Raltegravir Once-Daily Tablet: A Review in HIV-1 Infection

  • Drugs
  • 2017
VIEW 9 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2016
2019

CITATION STATISTICS

  • 17 Highly Influenced Citations

  • Averaged 56 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 206 REFERENCES

A case - control study of HIV seroconversion in health care workers after percutaneous exposure

RM Lynch, E Boritz, EE Coates
  • 2016

A patient navigation/contingency management RCT for hospitalized HIV+ substance users

LR Metsch, DJ Feaster, L Gooden
  • Presented at: Conference on Retroviruses and Opportunistic Infections; February
  • 2016

A single monotherapy dose of MK-8591, a novel NRTI, suppresses HIV for 10 days

E Friedman, D Schuermann, DJ Rudd
  • Presented at: Conference on Retroviruses and Opportunistic Infections; February
  • 2016

Antiretroviral treatment of adult HIV infection: Clinical Review & Education Special Communication 2016 Recommendations for Use of ARVs to Treat and Prevent Adult HIV Infection

MA Thompson, JA Aberg, JF Hoy
  • JAMA July
  • 2016

Antiretrovirals, fractures, and osteonecrosis in a large European HIV cohort

AH Borges, J Hoy, E Florence
  • Presented at: 23rd Conference on Retroviruses and Opportunistic Infections; February
  • 2016

Botswana is close to meeting UNAIDS 2020 goals of 90-90-90 coverage

T Gaolathe, K Wirth, MP Holme
  • Presented at: Conference on Retroviruses and Opportunistic Infections; February
  • 2016

Similar Papers

Loading similar papers…